The American Journal of Medicine
Volume 120, Issue 2, Supplement 1 , Pages S3-S8 , February 2007

Abdominal Obesity: Role in the Pathophysiology of Metabolic Disease and Cardiovascular Risk

References 

  1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–787
  2. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761–811
  3. Jee SH, Kim HJ, Lee J. Obesity, insulin resistance and cancer risk. Yonsei Med J. 2005;46:449–455
  4. Ferrannini E. Insulin resistance is central to the burden of diabetes. Diabetes Metab Rev. 1997;13:81–86
  5. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448–1454
  6. Reaven GM. Diet and syndrome X. Curr Atheroscler Rep. 2000;2:503–507
  7. Després JP. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. Exerc Sport Sci Rev. 1997;25:271–300
  8. Gill H, Mugo M, Whaley-Connell A, Stump C, Sowers JR. The key role of insulin resistance in the cardiometabolic syndrome. Am J Med Sci. 2005;330:290–294
  9. Boden-Albala B. Current understanding of multiple risk factors as the metabolic syndrome: distillation or deconstruction. Semin Neurol. 2006;26:108–116
  10. Kissebah AH. Central obesity: measurement and metabolic effects. Diabetes Rev. 1997;5:8–20
  11. Arner P. Not all fat is alike. Lancet. 1998;351:1301–1302
  12. Jensen MD. Lipolysis: contribution from regional fat. Annu Rev Nutr. 1997;17:127–139
  13. Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–468
  14. Kuo CS, Hwu CM, Chiang SC, et al. Waist circumference predicts insulin resistance in offspring of diabetic patients. Diabetes Nutr Metab. 2002;15:101–108
  15. Poirier P, Lemieux I, Mauriege P, et al. Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension. 2005;45:363–367
  16. Barzilai N, She L, Liu BQ, et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 1999;48:94–98
  17. Mittelman SD, Van Citters GW, Kim SP, et al. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes. 2000;49:2116–2125
  18. Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes. 2003;52:2453–2460
  19. Catalano KJ, Bergman RN, Kim SP, et al. Visceral fat depot with limited capacity determines insulin resistance in normal dogs. Obes Res. 2003;11(suppl):A71;[abstract]
  20. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 1994;93:2438–2446
  21. Lam TK, van de WG, Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab. 2003;284:E281–E290
  22. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid–induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade. Diabetes. 1999;48:1270–1274
  23. Ellmerer M, Kim SP, Hamilton-Wessler M, Hücking K, Kirkman E, Bergman RN. Physiological hyperinsulinemia in dogs augments access of macromolecules to insulin-sensitive tissues. Diabetes. 2004;53:2741–2747
  24. Ellmerer M, Hamilton-Wessler M, Kim SP, et al. Reduced access to insulin-sensitive tissues in dogs with obesity secondary to increased fat intake. Diabetes. 2006;55:1769–1775
  25. Kabir M, Catalano KJ, Ananthnarayan S, et al. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab. 2005;288:E454–E461
  26. Getty L, Panteleon AE, Mittelman SD, Dea MK, Bergman RN. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo. J Clin Invest. 2000;106:421–430
  27. Hücking K, Hamilton-Wessler M, Ellmerer M, Bergman RN. Burst-like control of lipolysis by the sympathetic nervous system in vivo. J Clin Invest. 2003;111:257–264
  28. Hsu IR, Zuniga E, Bergman RN. Importance of pulsatile changes in FFA for the enhancement of glucose output from the liver. Diabetes. 2006;55(suppl 1):4;[abstract]
  29. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001;19(pt 2):523–528
  30. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104:787–794
  31. Ward WK, Johnston CL, Beard JC, Benedetti TJ, Halter JB, Porte D. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes. 1985;34:861–869
  32. Groop L. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion. Int J Clin Pract Suppl. 2000;113:3–13
  33. Buchanan TA. Pancreatic beta-cell loss and preservation in type 2 diabetes. Clin Ther. 2003;25(suppl B):B32–B46
  34. Marigliano A, Tedde R, Sechi LA, Pala A, Pisanu G, Pacifico A. Insulinemia and blood pressure: relationships in patients with primary and secondary hypertension, and with or without glucose metabolism impairment. Am J Hypertens. 1990;3:521–526
  35. Stolar MW. Atherosclerosis in diabetes: the role of hyperinsulinemia. Metabolism. 1988;37(suppl 1):1–9
  36. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am J Med Sci. 2002;323:140–145

PII: S0002-9343(06)01361-1

doi: 10.1016/j.amjmed.2006.11.012

The American Journal of Medicine
Volume 120, Issue 2, Supplement 1 , Pages S3-S8 , February 2007

Article Tools

* Image Usage & Resolution